Search - tctmd.com

Displaying 701 - 720 of 1217

Sort: Relevancy | Date

As Pragmatic Trials Gain Steam, Beware the Pitfalls of Claims Data

News Daily News

As Pragmatic Trials Gain Steam, Beware the Pitfalls of Claims Data

June 07, 2017

DANAMI3-DEFER Substudy Affirms Lack of Benefit for Routinely Deferring Stenting in STEMI

News Daily News

DANAMI3-DEFER Substudy Affirms Lack of Benefit for Routinely Deferring Stenting in STEMI

June 05, 2017

How Low Can You Go? Concerns Over Aggressive LDL Lowering Eased as PCSK9 Evidence Mounts

News Features

How Low Can You Go? Concerns Over Aggressive LDL Lowering Eased as PCSK9 Evidence Mounts

Michael O'Riordan

May 23, 2017

Best Antiplatelet Therapy in Real-World PCI? European Registries Fuel the Debate

News Conference News EuroPCR 2017

Best Antiplatelet Therapy in Real-World PCI? European Registries Fuel the Debate

May 22, 2017

Large US Study Suggests Little Difference Between Bivalirudin and Heparin for Transradial Primary PCI

News Daily News

Large US Study Suggests Little Difference Between Bivalirudin and Heparin for Transradial Primary PCI

May 22, 2017

Scaffold Thrombosis ‘Unpredictable’ With Absorb: AIDA Analysis

News Conference News EuroPCR 2017

Scaffold Thrombosis ‘Unpredictable’ With Absorb: AIDA Analysis

Michael O'Riordan

May 19, 2017

News Conference News EuroPCR 2017

Transradial PCI in ACS Reduces Risk of Acute Kidney Injury

Michael O'Riordan

May 18, 2017

Minority Women Face 50% Increased Risk of Death/MI After PCI Compared With White Men at 1 Year

News Conference News SCAI 2017

Minority Women Face 50% Increased Risk of Death/MI After PCI Compared With White Men at 1 Year

May 18, 2017

iFR and FFR Equally Safe for Deferring Revascularization, Pooled Analysis Shows

News Conference News EuroPCR 2017

iFR and FFR Equally Safe for Deferring Revascularization, Pooled Analysis Shows

May 16, 2017

Big Questions for Bioresorbable Scaffolds: Experts and Innovators Debate

News Conference News EuroPCR 2017

Big Questions for Bioresorbable Scaffolds: Experts and Innovators Debate

Michael O'Riordan

May 15, 2017

Domo Arigato: High Success Rates, Low Radiation with Both Radial and Femoral Robotic PCI

News Conference News SCAI 2017

Domo Arigato: High Success Rates, Low Radiation With Both Radial and Femoral Robotic PCI

May 12, 2017

$2 Billion Annual Price Tag for FOURIER-Eligible VA Patients on PCSK9 Inhibitor

News Daily News

$2 Billion Annual Price Tag for FOURIER-Eligible VA Patients on PCSK9 Inhibitor

Michael O'Riordan

May 12, 2017

Absorb in Europe: When, How, and by Whom the Beleaguered BVS Is Being Used After Restrictions

News Features

Absorb in Europe: When, How, and by Whom the Beleaguered BVS Is Being Used After Restrictions

Michael O'Riordan

May 08, 2017

More Excess Bleeding and No Benefit With Triple Therapy After PCI, Meta-analysis Finds

News Daily News

More Excess Bleeding and No Benefit With Triple Therapy After PCI, Meta-analysis Finds

May 05, 2017

Stents as Essential Medicine: India’s Cap on Stent Prices Could Have Ripples Around the Globe

News Features

Stents as Essential Medicine: India’s Cap on Stent Prices Could Have Ripples Around the Globe

May 05, 2017

Thirty-Day Readmission in Acute MI Not Linked With Hospital Care or Clinical Outcomes

News Daily News

Thirty-Day Readmission in Acute MI Not Linked With Hospital Care or Clinical Outcomes

Michael O'Riordan

April 27, 2017

Absorb Comparable to Xience in Economic Analysis, but BVS Safety Concerns Could Alter Balance

News Daily News

Absorb Comparable to Xience in Economic Analysis, but BVS Safety Concerns Could Alter Balance

Michael O'Riordan

April 18, 2017

Running a Risk: Marathon Cities See Treatment Delays, More Cardiac Deaths Among Non-Race Participants

News Daily News

Running a Risk: Marathon Cities See Treatment Delays, More Cardiac Deaths Among Non-Race Participants

April 13, 2017

The Left Main Debate: What Does it Mean for the Future of Intervention?

News Opinion Fellow Talk

The Left Main Debate: What Does it Mean for the Future of Intervention?

Tiffany Patterson, MBBS

April 12, 2017

ICTUS: No Benefit at 10 Years With Early Invasive Strategy in NSTE ACS Patients

News Daily News

ICTUS: No Benefit at 10 Years With Early Invasive Strategy in NSTE ACS Patients

Michael O'Riordan

April 11, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.